IGC Pharma (IGC) Prepaid Assets (2011 - 2026)
IGC Pharma (IGC) posted quarterly Prepaid Assets of $18000.0 for Q1 2026, down 94.74% year-over-year from $342000.0 in Q1 2025, and down 85.48% quarter-over-quarter from $124000.0 in Q4 2025.
IGC Pharma (IGC) Prepaid Assets (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Prepaid Assets for 16 consecutive years, with $18000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 94.74% year-over-year to $18000.0; the TTM figure through Mar 2026 stood at $18000.0 (down 94.74% YoY), while the FY2026 annual figure was $18000.0, down 94.74% from the prior year.
- Prepaid Assets retreated to $18000.0 in Q1 2026 per IGC's latest filing, from $124000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $434000.0 in Q3 2024 and bottomed at $18000.0 in Q1 2026.
- Historically, Prepaid Assets has averaged $211764.7 across 5 years, with a median of $208000.0 in 2024.
- Annual changes were most pronounced in 2024 — Prepaid Assets jumped 600.0% — and 2026, when it tumbled 94.74%.
- IGC Pharma's Prepaid Assets stood at $322000.0 in 2022, then slumped by 41.61% to $188000.0 in 2023, then jumped by 111.7% to $398000.0 in 2024, then slumped by 68.84% to $124000.0 in 2025, then tumbled by 85.48% to $18000.0 in 2026.
- Business Quant data shows IGC's Prepaid Assets at $18000.0 in Q1 2026, $124000.0 in Q4 2025, and $25000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 124,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 148,000.00 |
| Mar 31, 2025 | 342,000.00 |
| Dec 31, 2024 | 398,000.00 |
| Sep 30, 2024 | 434,000.00 |
| Jun 30, 2024 | 240,000.00 |
| Mar 31, 2024 | 208,000.00 |
| Dec 31, 2023 | 188,000.00 |
| Sep 30, 2023 | 62,000.00 |
| Jun 30, 2023 | 262,000.00 |
| Mar 31, 2023 | 262,000.00 |
| Dec 31, 2022 | 322,000.00 |
| Sep 30, 2022 | 146,000.00 |
| Jun 30, 2022 | 251,000.00 |
| Mar 31, 2022 | 170,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Jun 30, 2021 | 207,000.00 |
| Mar 31, 2021 | 196,000.00 |